HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Huimin Yi Selected Research
Huimin Yi Research Topics
Disease
8
Acute Lung Injury
01/2024 - 05/2018
6
Infections
01/2023 - 11/2015
3
Inflammation (Inflammations)
01/2024 - 07/2010
2
Acute Kidney Injury (Acute Renal Failure)
11/2020 - 10/2020
2
Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
10/2020 - 01/2020
2
Liver Diseases (Liver Disease)
11/2015 - 10/2014
1
Pulmonary Edema
01/2024
1
Pneumonia (Pneumonitis)
01/2022
1
Ventilator-Associated Pneumonia
01/2022
1
Cross Infection (Nosocomial Infection)
01/2022
1
Liver Failure
01/2021
1
Intraabdominal Infections
12/2020
1
Fistula
12/2020
1
Respiratory Insufficiency (Respiratory Failure)
01/2020
1
Jaundice (Icterus)
11/2015
1
Hypotension (Low Blood Pressure)
11/2015
1
Hepatocellular Carcinoma (Hepatoma)
03/2015
1
Neoplasms (Cancer)
03/2015
1
Hepatopulmonary Syndrome
10/2014
1
End Stage Liver Disease
10/2014
Drug/Important Bio-Agent (IBA)
7
Lipopolysaccharides
IBA
01/2024 - 10/2014
1
Hematoxylin (Haematoxylon)
IBA
01/2024
1
Interleukin-6 (Interleukin 6)
IBA
01/2024
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2024
1
Uridine Triphosphate (UTP)
IBA
01/2024
1
Immunosorbents
IBA
01/2024
1
Interleukins
IBA
01/2024
1
Circular RNA
IBA
01/2024
1
DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)
IBA
01/2024
1
Enzymes
IBA
01/2024
1
Eosine Yellowish-(YS) (Eosin)
IBA
01/2024
1
NF-kappa B (NF-kB)
IBA
01/2024
1
Cholinergic Receptors
IBA
01/2022
1
Tigecycline (Tygacil)
FDA Link
01/2022
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2022
1
Choline O-Acetyltransferase (Choline Acetyltransferase)
IBA
01/2022
1
Evans Blue (Blue, Evans)
FDA Link
01/2022
1
Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)
IBA
01/2022
1
Lobeline (Smokeless)
IBA
01/2022
1
Polymyxin B (Aerosporin)
FDA Link
Generic
01/2022
1
Rituximab (Mabthera)
FDA Link
01/2021
1
Inflammasomes
IBA
01/2021
1
urinastatin (MR 20)
IBA
11/2020
1
Tissue Inhibitor of Metalloproteinase-2
IBA
10/2020
1
Insulin-Like Growth Factor Binding Proteins
IBA
10/2020
1
Antioxidants
IBA
03/2020
1
Fluorescent Dyes (Fluorescent Probes)
IBA
05/2018
1
Vasoconstrictor Agents
IBA
11/2015
1
Globulins
IBA
11/2015
1
Therapeutic Uses
IBA
11/2015
1
Albumins
IBA
11/2015
1
Small Interfering RNA (siRNA)
IBA
03/2015
1
Matrix Metalloproteinase 2 (Gelatinase A)
IBA
03/2015
1
Telomerase (Telomerase Reverse Transcriptase)
IBA
03/2015
1
Cell-Penetrating Peptides
IBA
03/2015
1
Dipeptidyl-Peptidase IV Inhibitors
IBA
07/2010
Therapy/Procedure
4
Therapeutics
01/2023 - 03/2015
3
Liver Transplantation
01/2021 - 10/2014
1
Spinal Injections
01/2022
1
Length of Stay
01/2022
1
Artificial Respiration (Mechanical Ventilation)
01/2022
1
Topical Administration
01/2021
1
Critical Care (Surgical Intensive Care)
12/2020
1
Salvage Therapy
10/2020
1
Plasmapheresis
11/2015
1
Hemofiltration
11/2015